Zealand Pharma

This study looks at the long-term safety and effectiveness of a drug called glepaglutide in adults with short bowel syndrome (SBS). Participants who were already in earlier trials can continue treatment for up to 2 years. The goal is to see if the drug remains safe and helps redu…

This study tests the long-term safety and effectiveness of a weekly injection called glepaglutide in adults with short bowel syndrome, a condition where the body can't absorb nutrients properly. About 129 people who completed a prior trial will receive the drug for 2 years. The g…

This study tests the long-term safety of glepaglutide, a medicine for people with short bowel syndrome (SBS). SBS makes it hard for the body to absorb nutrients from food. The trial involves 145 adults who have already taken part in earlier studies. Researchers will track side ef…

This study tests a new weekly injection called petrelintide to help people with overweight or obesity and type 2 diabetes lose weight. About 221 adults will receive either the drug or a placebo for several weeks. The main goal is to see how much weight they lose and how their blo…

This study tests the long-term safety of a drug called dasiglucagon in children with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. About 42 children who completed earlier trials will receive dasiglucagon as a continuous shot under the skin. The…